2. Academic Validation
  3. Small-Molecule Inhibitor of the Oncogenic KRASG12C Mutant for the Treatment of Currently Incurable Cancer

Small-Molecule Inhibitor of the Oncogenic KRASG12C Mutant for the Treatment of Currently Incurable Cancer

  • ACS Med Chem Lett. 2022 Apr 20;13(5):767-769. doi: 10.1021/acsmedchemlett.2c00152.
Robert B Kargbo 1
Affiliations

Affiliation

  • 1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
PMID: 35586420 DOI: 10.1021/acsmedchemlett.2c00152
Figures
Products